首页> 外国专利> LIVER-TYPE FATTY-ACID BINDING PROTEIN MARKER, EVALUATION METHOD OF MARKER, METHOD OF SUPPRESSING FLUCTUATION RANGE OF MEASURED VALUE RESULTING FROM LIVER-TYPE FATTY ACID BINDING PROTEIN MEASURED USING MARKER, METHOD OF FORMING CALIBRATION CURVE OF LIVER-TYPE FATTY ACID BINDING PROTEIN, AND METHOD OF QUANTIFYING PROTEIN

LIVER-TYPE FATTY-ACID BINDING PROTEIN MARKER, EVALUATION METHOD OF MARKER, METHOD OF SUPPRESSING FLUCTUATION RANGE OF MEASURED VALUE RESULTING FROM LIVER-TYPE FATTY ACID BINDING PROTEIN MEASURED USING MARKER, METHOD OF FORMING CALIBRATION CURVE OF LIVER-TYPE FATTY ACID BINDING PROTEIN, AND METHOD OF QUANTIFYING PROTEIN

机译:肝型脂肪酸结合蛋白标记物,标记物的评估方法,抑制通过标记物测定的肝型脂肪酸结合蛋白产生的测量值波动范围的方法,形成校准标记的方法,肝状蛋白原型的校正曲线和蛋白质定量方法

摘要

PROBLEM TO BE SOLVED: To provide a liver-type fatty acid binding protein marker that can reduce the range of fluctuations of measured values resulting from liver-type fatty acid binding protein measured using a substance that specifically binds thereto, a method of evaluating said marker, a method of creating a calibration curve of the liver-type fatty acid binding protein, and method of quantifying protein.;SOLUTION: The liver-type fatty acid binding protein marker comprises an amino acid sequence with 90% or more sequence identity to sequence number 1 in the sequence table in which the oxidation rate of the methionine at position 19 is 30% or more, and the oxidation rate of the methionine at position 113 is 70% or more. The liver-type fatty acid binding protein marker comprises a liver-type fatty acid binding protein comprising an amino acid sequence with 90% or more sequence identity to sequence number 1 in the sequence table and, with respect to the molar ratio of the liver-type fatty acid binding protein, the molar ratio of at least one type of fatty acid selected from the group consisting of arachidonic acid, oleic acid, 8-isoprostaglandin F and 2,3-dinor-8-isoprostaglandin F is 30 times or more.;SELECTED DRAWING: Figure 1;COPYRIGHT: (C)2018,JPO&INPIT
机译:解决的问题:提供一种肝型脂肪酸结合蛋白标记物,其可以减少由使用与之特异性结合的物质测量的肝型脂肪酸结合蛋白所产生的测量值波动范围,一种评估所述标记物的方法,创建肝脏型脂肪酸结合蛋白校准曲线的方法和定量蛋白质的方法;解决方案:肝脏型脂肪酸结合蛋白标记包含与序列具有90%或更高序列同一性的氨基酸序列序列表中的编号1,其中在位置19的蛋氨酸的氧化率为30%以上,在位置113的蛋氨酸的氧化率为70%以上。肝型脂肪酸结合蛋白标记物包括肝型脂肪酸结合蛋白,其包含与序列表中的序列号1具有90%或更高序列同一性的氨基酸序列,并且相对于肝-型脂肪酸结合蛋白,选自花生四烯酸,油酸,8-异前列腺素F 和2,3-dinor-8-的至少一种脂肪酸的摩尔比异前列腺素F 是其30倍或更多倍;选图:图1;版权:(C)2018,JPO&INPIT

著录项

  • 公开/公告号JP2018100256A

    专利类型

  • 公开/公告日2018-06-28

    原文格式PDF

  • 申请/专利权人 CMIC HOLDINGS CO LTD;

    申请/专利号JP20170077664

  • 申请日2017-04-10

  • 分类号C07K14/47;G01N33/53;G01N33/50;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 13:12:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号